Provided by Tiger Trade Technology Pte. Ltd.

Allstate

202.71
-4.4500-2.15%
Post-market: 200.43-2.2800-1.12%19:17 EDT
Volume:1.29M
Turnover:262.89M
Market Cap:52.72B
PE:5.33
High:209.40
Open:209.40
Low:201.61
Close:207.16
52wk High:216.75
52wk Low:176.00
Shares:260.10M
Float Shares:260.10M
Volume Ratio:0.76
T/O Rate:0.50%
Dividend:4.00
Dividend Rate:1.97%
EPS(TTM):38.06
EPS(LYR):38.06
ROE:39.52%
ROA:6.49%
PB:1.84
PE(LYR):5.33

Loading ...

Allstate Corp - Announces November Catastrophe Losses of $46 Mln - SEC Filing

THOMSON REUTERS
·
Dec 18, 2025

Allstate Reports $46 Million in November Catastrophe Losses and 1.5% Annual Growth in Policies in Force

Reuters
·
Dec 18, 2025

U.S. RESEARCH ROUNDUP-Autozone, Coursera, Lennar

Reuters
·
Dec 18, 2025

Allstate Chairman, President & CEO Thomas J. Wilson Reports Disposal of Common Shares

Reuters
·
Dec 18, 2025

Aristocrat Leisure (ASX:ALL): Valuation Check After Buyback Update, 2025 Report and Fitch Rating Upgrade

Simply Wall St.
·
Dec 16, 2025

Allstate Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
Dec 16, 2025

Allstate Corp : Mizuho Initiates Coverage With Outperform Rating; Price Target $254

THOMSON REUTERS
·
Dec 16, 2025

Mizuho Initiates Allstate at Outperform With $254 Price Target

MT Newswires Live
·
Dec 16, 2025

Allstate Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 16, 2025

ALL CONEC Signs MOU with MINIMAX to Accelerate Global Digital Dental Expansion

prnewswire
·
Dec 13, 2025

Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025

GlobeNewswire
·
Dec 12, 2025

Allstate Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Dec 12, 2025

Wolfe Research Adjusts Allstate Price Target to $244 From $250, Maintains Outperform Rating

MT Newswires Live
·
Dec 11, 2025

Fitch Upgrade and Unsecured Structure Shift Could Be A Game Changer For Aristocrat Leisure (ASX:ALL)

Simply Wall St.
·
Dec 11, 2025

The Bull Case For Allstate (ALL) Could Change Following Mixed Revenue And Earnings Beat – Learn Why

Simply Wall St.
·
Dec 10, 2025

Allstate Unveils Strategy to Boost Market Share and Enhance Operating Performance

Reuters
·
Dec 10, 2025

AI CAD-OCI Integration Underway: ALL CONEC Begins Validation of Digital Prosthetic Data Workflow

prnewswire
·
Dec 09, 2025

DC Holdings (00861) Reallocates Funds to Focus on "AI + Supply Chain" Sector

Stock News
·
Dec 09, 2025

ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%

GlobeNewswire
·
Dec 09, 2025

Autolus Therapeutics Presents Initial Clinical Data in Pediatric r/r B-ALL Patients and Other Oncology Data at the American Society of Hematology (ASH) Annual Meeting 2025

GlobeNewswire
·
Dec 08, 2025